• Summary
  • Table Of Content
  • Segmentation
  • Request sample

Global Home Infusion Therapy Market Overview

The Global Home Infusion Therapy Market size is expected to grow from USD 22.98 billion in 2023 to USD 40.92 billion by 2032, at a CAGR of 6.62% during the forecast period (2024-2032).

Home infusion therapy is a rapidly growing segment within the healthcare industry, providing patients with the convenience and comfort of receiving intravenous medications or fluids in their own homes rather than in a hospital or clinic setting. This form of treatment is typically used for patients requiring long-term care for conditions such as infections, immune deficiencies, dehydration, chemotherapy, and pain management. The therapy involves skilled healthcare professionals administering medications through various infusion methods, ensuring patients receive proper dosage and monitoring.

The industry has seen significant expansion due to several factors. Firstly, an aging population with complex medical needs prefers home-based care for its comfort and reduced risk of hospital-acquired infections. Secondly, advancements in medical technology and infusion devices have made it easier and safer to administer treatments outside of traditional healthcare settings. Moreover, healthcare policies and reimbursement structures increasingly favor home infusion therapy as a cost-effective alternative to hospital stays, promoting its adoption among healthcare providers and insurers.

Key stakeholders in the home infusion therapy industry include specialized pharmacies, home healthcare providers, infusion nurses, and medical equipment suppliers. These entities collaborate closely to ensure seamless delivery of care, from prescribing medications to monitoring patient outcomes. Regulatory bodies such as the Centers for Medicare & Medicaid Services (CMS) and accreditation organizations set standards to ensure quality and safety in home infusion services, further driving the professionalism and reliability of providers in the industry.

Market Dynamics and Key Factors of Home Infusion Therapy:

Drivers:

Hospital-Like Care at Home
Patients can receive an innovative and comprehensive set of services with a variety of care alternatives when they choose home infusion services. Home services can help patients to avoid extended hospital stays and high medical fees by providing care in the comfort of the home. Individuals can receive IV infusions in a comfortable and safe atmosphere as part of several infusion therapies. With the guidance of a trustworthy health provider, a patient recovering from surgery or undergoing surgery therapy can access a variety of home care infusion services. Professionals can assist patients with all types of infusions, from the first interaction with the client to providing professional home therapy.

To reduce the strain on the primary healthcare services
The market is expected to grow in response to the growing need to shorten inpatient stays. According to the American Hospital Association, there were approximately 36,241,815 hospital admissions in all US hospitals in 2019. This has prompted the development of ways for administering infusion therapy at home or in other healthcare settings, which is expected to boost the market growth. While hospitals have quickly adopted smart infusion pumps with useful features like EHR connection, drug libraries, and medication safety software, most home infusion providers still use classic infusion pumps. However, due to rising demand, there has been a growing trend for equipment upgrades, particularly in developed countries thus, supporting the development of the home infusion therapy market over the forecast period.

Restraints:

Third-Party service providers and low reimbursement policies

The issue of fragmented care may develop in the home infusion setting if the home infusion provider is a third-party company that is not part of the patient's primary care team. Concerns about the patient's limited access to their care team may also cause issues, as eliminating the requirement for patients to visit the clinic for each infusion reduces their interaction with their provider. Other issues that may develop include the patient's potential limited access to emergency services if a negative reaction or adverse event (AE) occurs during the infusion thus, hampering the growth of the market over the projected timeframe.

Opportunities:

Growing Geriatric Population
According to the United Nations, the world's population will grow by one billion people by 2025, with roughly a third of them being 65 or older as life expectancy rises. Middle-class comforts and urbanization are also on the rise, potentially leading to more sedentary lifestyles and chronic illnesses. There is concern that all of this will place a further strain on the global health system's ability to administer and pay for care. As a result, there has been a significant shift in healthcare toward a more patient-centered, community-based approach. Regulations in the healthcare industry have supported the growth of the home infusion therapy market. For instance, healthcare systems in the USA are implementing new guidelines to support home infusion therapies thus, creating a lucrative opportunity for the market players.

Market Segmentation

By product type, the infusion pump segment is anticipated to have the highest share of the home infusion therapy market. It is projected to record a 5.4% CAGR and reach USD 18.2 billion by the end of the analysis period. Infusion pumps have numerous benefits over manual fluid administration, including the ability to give fluids in very small quantities and at precisely programmed rates or automatic intervals. They can be utilized to administer nutrients or pharmaceuticals like insulin or other hormones, antibiotics, chemotherapeutic treatments, and pain relievers. Large volume, patient-controlled analgesia (PCA), elastomeric, syringe, enteral, and insulin pumps are among the various types of infusion pumps available.

By infusion type, the continuous segment is estimated to dominate the infusion therapy market. Continuous infusion maintains a constant concentration of microbubbles, lowering the risk of artifacts. If there is a steady-state concentration of contrast, it is also possible to compute myocardial blood flow, as both myocardial blood volume and microbubble velocity can be calculated. Continuous infusion strategies have been found in studies to be the best options for drug administration in cancer patients thus, supporting the growth of the segment.

By application, the anti-infective segment is anticipated to lead the growth of the home infusion therapy market. One of the most regularly prescribed home infusion therapies is anti-infective therapy (antibiotics, antifungals, and antivirals), which can be safely managed at home. Cystic fibrosis, Lyme disease, Osteomyelitis, and other infections that require long-term anti-infective therapy can all be caused by a variety of causes. If not treated properly, each of these clinical disorders can lead to unnecessary hospitalization and/or emergency room visits. These disorders can be treated at home using infusion therapy, which can help avert life-threatening situations thus, boosting the development of the segment.

Players Covered in Home Infusion Therapy market are :

  • CVS/Coram
  • Option Care Health
  • BriovaRx/Diplomat (UnitedHealth Optum)
  • PharMerica
  • Fresenius Kabi
  • ICU Medical Inc.
  • B. Braun Melsungen AG
  • Baxter
  • BD
  • Caesarea Medical Electronics
  • Smiths Medical
  • Terumo Corporation
  • JMS Co. Ltd and others major players.

Regional Analysis of Home Infusion Therapy Market:

In North America, particularly in the United States and Canada, the home infusion therapy market is well-established and growing steadily. Factors driving this growth include a large elderly population with chronic conditions, favorable reimbursement policies from Medicare and private insurers, and advanced healthcare infrastructure supporting home-based care. The region also benefits from a robust network of specialty pharmacies and home healthcare providers offering comprehensive infusion services, coupled with stringent regulatory standards ensuring patient safety and quality of care.

In Europe, the home infusion therapy sector is expanding as healthcare systems increasingly prioritize cost-effective care delivery and patient-centered services. Countries like the United Kingdom, Germany, and France lead in adopting home-based infusion therapies, driven by aging populations and a shift towards reducing hospital admissions. Regulatory harmonization across the European Union facilitates cross-border collaboration among healthcare providers and promotes standardization of care practices.

Overall, regional variations in healthcare systems, regulatory environments, economic conditions, and patient preferences shape the development and adoption of home infusion therapy globally. As the industry continues to evolve, stakeholders must navigate these diverse landscapes to capitalize on opportunities and address challenges in delivering quality, accessible care to patients in their homes.

Recent Industry Developments in Home Infusion Therapy Market

  • In January 2024, BrightStar Care collaborated with Paragon Healthcare to offer high-quality home infusion services. This strategic collaboration enables Paragon Healthcare to efficiently enhance the delivery of high-quality home infusion services to a broader clientele through BrightStar Care's nurse-led, Joint Commission-accredited care model.
  • In January 2023, KORU Medical Systems, Inc. has partnered with a pharmaceutical manufacturer to develop and approve the Freedom Infusion System, which uses a prefilled syringe for subcutaneous immunoglobulin therapy (SCIg). The system includes Freddom60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets for home and alternate care settings.

Global Home Infusion Therapy Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 22.98 Bn.

Forecast Period 2024-32 CAGR:

6.62%

Market Size in 2032:

USD 40.92 Bn.

Segments Covered:

By Type

  • IV Cannulas
  • Infusion Pumps
  • Needleless Connectors
  • Intravenous Sets

By  Infusion Type

  • Continuous
  • Secondary IV
  • IV Push

By Application

  • Anti-Infective
  • Endocrinology
  • Enteral Nutrition
  • Parenteral Nutrition
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Hospital-Like Care at Home

Key Market Restraints:

  • Third-Party Service Providers and Low Reimbursement Policies

Key Opportunities:

  • Growing Geriatric Population

Companies Covered in the report:

  • CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc, and Other Major Players

Chapter 1: Introduction
ā€ƒ1.1 Research Objectives
ā€ƒ1.2 Research Methodology
ā€ƒ1.3 Research Process
ā€ƒ1.4 Scope and Coverage
ā€ƒā€ƒ1.4.1 Market Definition
ā€ƒā€ƒ1.4.2 Key Questions Answered
ā€ƒ1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
ā€ƒ3.1 By Type
ā€ƒ3.2 By Infusion Type
ā€ƒ3.3 By Application

Chapter 4: Market Landscape
ā€ƒ4.1 Porter's Five Forces Analysis
ā€ƒā€ƒ4.1.1 Bargaining Power of Supplier
ā€ƒā€ƒ4.1.2 Threat of New Entrants
ā€ƒā€ƒ4.1.3 Threat of Substitutes
ā€ƒā€ƒ4.1.4 Competitive Rivalry
ā€ƒā€ƒ4.1.5 Bargaining Power Among Buyers
ā€ƒ4.2 Industry Value Chain Analysis
ā€ƒ4.3 Market Dynamics
ā€ƒā€ƒ4.3.1 Drivers
ā€ƒā€ƒ4.3.2 Restraints
ā€ƒā€ƒ4.3.3 Opportunities
ā€ƒā€ƒ4.5.4 Challenges
ā€ƒ4.4 Pestle Analysis
ā€ƒ4.5 Technological Roadmap
ā€ƒ4.6 Regulatory Landscape
ā€ƒ4.7 SWOT Analysis
ā€ƒ4.8 Price Trend Analysis
ā€ƒ4.9 Patent Analysis
ā€ƒ4.10 Analysis of the Impact of Covid-19
ā€ƒā€ƒ4.10.1 Impact on the Overall Market
ā€ƒā€ƒ4.10.2 Impact on the Supply Chain
ā€ƒā€ƒ4.10.3 Impact on the Key Manufacturers
ā€ƒā€ƒ4.10.4 Impact on the Pricing

Chapter 5: Home Infusion Therapy Market by Type
ā€ƒ5.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā€ƒ5.2 Home Infusion Therapy Market Overview
ā€ƒ5.3 IV Cannulas
ā€ƒā€ƒ5.3.1 Introduction and Market Overview
ā€ƒā€ƒ5.3.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ5.3.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ5.3.4 IV Cannulas: Grographic Segmentation
ā€ƒ5.4 Infusion Pumps
ā€ƒā€ƒ5.4.1 Introduction and Market Overview
ā€ƒā€ƒ5.4.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ5.4.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ5.4.4 Infusion Pumps: Grographic Segmentation
ā€ƒ5.5 Needleless Connectors
ā€ƒā€ƒ5.5.1 Introduction and Market Overview
ā€ƒā€ƒ5.5.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ5.5.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ5.5.4 Needleless Connectors: Grographic Segmentation
ā€ƒ5.6 Intravenous Sets
ā€ƒā€ƒ5.6.1 Introduction and Market Overview
ā€ƒā€ƒ5.6.2 Historic and Forecasted Market Size (2016-2028F)
ā€ƒā€ƒ5.6.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ5.6.4 Intravenous Sets: Grographic Segmentation

Chapter 6: Home Infusion Therapy Market by Infusion Type
ā€ƒ6.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā€ƒ6.2 Home Infusion Therapy Market Overview
ā€ƒ6.3 Continuous
ā€ƒā€ƒ6.3.1 Introduction and Market Overview
ā€ƒā€ƒ6.3.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ6.3.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ6.3.4 Continuous: Grographic Segmentation
ā€ƒ6.4 Secondary IV
ā€ƒā€ƒ6.4.1 Introduction and Market Overview
ā€ƒā€ƒ6.4.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ6.4.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ6.4.4 Secondary IV: Grographic Segmentation
ā€ƒ6.5 IV Push
ā€ƒā€ƒ6.5.1 Introduction and Market Overview
ā€ƒā€ƒ6.5.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ6.5.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ6.5.4 IV Push: Grographic Segmentation

Chapter 7: Home Infusion Therapy Market by Application
ā€ƒ7.1 Home Infusion Therapy Market Overview Snapshot and Growth Engine
ā€ƒ7.2 Home Infusion Therapy Market Overview
ā€ƒ7.3 Anti-Infective
ā€ƒā€ƒ7.3.1 Introduction and Market Overview
ā€ƒā€ƒ7.3.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ7.3.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ7.3.4 Anti-Infective: Grographic Segmentation
ā€ƒ7.4 Endocrinology
ā€ƒā€ƒ7.4.1 Introduction and Market Overview
ā€ƒā€ƒ7.4.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ7.4.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ7.4.4 Endocrinology: Grographic Segmentation
ā€ƒ7.5 Enteral Nutrition
ā€ƒā€ƒ7.5.1 Introduction and Market Overview
ā€ƒā€ƒ7.5.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ7.5.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ7.5.4 Enteral Nutrition: Grographic Segmentation
ā€ƒ7.6 Parenteral Nutrition
ā€ƒā€ƒ7.6.1 Introduction and Market Overview
ā€ƒā€ƒ7.6.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ7.6.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ7.6.4 Parenteral Nutrition: Grographic Segmentation
ā€ƒ7.7 Others
ā€ƒā€ƒ7.7.1 Introduction and Market Overview
ā€ƒā€ƒ7.7.2 Historic and Forecasted Market Size (2017-2032F)
ā€ƒā€ƒ7.7.3 Key Market Trends, Growth Factors and Opportunities
ā€ƒā€ƒ7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
ā€ƒ8.1 Competitive Landscape
ā€ƒā€ƒ8.1.1 Competitive Positioning
ā€ƒā€ƒ8.1.2 Home Infusion Therapy Sales and Market Share By Players
ā€ƒā€ƒ8.1.3 Industry BCG Matrix
ā€ƒā€ƒ8.1.4 Ansoff Matrix
ā€ƒā€ƒ8.1.5 Home Infusion Therapy Industry Concentration Ratio (CR5 and HHI)
ā€ƒā€ƒ8.1.6 Top 5 Home Infusion Therapy Players Market Share
ā€ƒā€ƒ8.1.7 Mergers and Acquisitions
ā€ƒā€ƒ8.1.8 Business Strategies By Top Players
ā€ƒ8.2 CVS/CORAM
ā€ƒā€ƒ8.2.1 Company Overview
ā€ƒā€ƒ8.2.2 Key Executives
ā€ƒā€ƒ8.2.3 Company Snapshot
ā€ƒā€ƒ8.2.4 Operating Business Segments
ā€ƒā€ƒ8.2.5 Product Portfolio
ā€ƒā€ƒ8.2.6 Business Performance
ā€ƒā€ƒ8.2.7 Key Strategic Moves and Recent Developments
ā€ƒā€ƒ8.2.8 SWOT Analysis
ā€ƒ8.3 OPTION CARE HEALTH
ā€ƒ8.4 BRIOVARX/DIPLOMAT (UNITEDHEALTH OPTUM)
ā€ƒ8.5 PHARMERICA
ā€ƒ8.6 FRESENIUS KABI
ā€ƒ8.7 ICU MEDICAL INC.
ā€ƒ8.8 B. BRAUN MELSUNGEN AG
ā€ƒ8.9 BAXTER
ā€ƒ8.10 BD
ā€ƒ8.11 CAESAREA MEDICAL ELECTRONICS
ā€ƒ8.12 SMITHS MEDICAL
ā€ƒ8.13 TERUMO CORPORATION
ā€ƒ8.14 JMS CO. LTD.
ā€ƒ8.15 OTHERS MAJOR PLAYERS

Chapter 9: Global Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā€ƒ9.1 Market Overview
ā€ƒ9.2 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ9.2.1 IV Cannulas
ā€ƒā€ƒ9.2.2 Infusion Pumps
ā€ƒā€ƒ9.2.3 Needleless Connectors
ā€ƒā€ƒ9.2.4 Intravenous Sets
ā€ƒ9.3 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ9.3.1 Continuous
ā€ƒā€ƒ9.3.2 Secondary IV
ā€ƒā€ƒ9.3.3 IV Push
ā€ƒ9.4 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ9.4.1 Anti-Infective
ā€ƒā€ƒ9.4.2 Endocrinology
ā€ƒā€ƒ9.4.3 Enteral Nutrition
ā€ƒā€ƒ9.4.4 Parenteral Nutrition
ā€ƒā€ƒ9.4.5 Others

Chapter 10: North America Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā€ƒ10.1 Key Market Trends, Growth Factors and Opportunities
ā€ƒ10.2 Impact of Covid-19
ā€ƒ10.3 Key Players
ā€ƒ10.4 Key Market Trends, Growth Factors and Opportunities
ā€ƒ10.4 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ10.4.1 IV Cannulas
ā€ƒā€ƒ10.4.2 Infusion Pumps
ā€ƒā€ƒ10.4.3 Needleless Connectors
ā€ƒā€ƒ10.4.4 Intravenous Sets
ā€ƒ10.5 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ10.5.1 Continuous
ā€ƒā€ƒ10.5.2 Secondary IV
ā€ƒā€ƒ10.5.3 IV Push
ā€ƒ10.6 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ10.6.1 Anti-Infective
ā€ƒā€ƒ10.6.2 Endocrinology
ā€ƒā€ƒ10.6.3 Enteral Nutrition
ā€ƒā€ƒ10.6.4 Parenteral Nutrition
ā€ƒā€ƒ10.6.5 Others
ā€ƒ10.7 Historic and Forecast Market Size by Country
ā€ƒā€ƒ10.7.1 U.S.
ā€ƒā€ƒ10.7.2 Canada
ā€ƒā€ƒ10.7.3 Mexico

Chapter 11: Europe Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā€ƒ11.1 Key Market Trends, Growth Factors and Opportunities
ā€ƒ11.2 Impact of Covid-19
ā€ƒ11.3 Key Players
ā€ƒ11.4 Key Market Trends, Growth Factors and Opportunities
ā€ƒ11.4 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ11.4.1 IV Cannulas
ā€ƒā€ƒ11.4.2 Infusion Pumps
ā€ƒā€ƒ11.4.3 Needleless Connectors
ā€ƒā€ƒ11.4.4 Intravenous Sets
ā€ƒ11.5 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ11.5.1 Continuous
ā€ƒā€ƒ11.5.2 Secondary IV
ā€ƒā€ƒ11.5.3 IV Push
ā€ƒ11.6 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ11.6.1 Anti-Infective
ā€ƒā€ƒ11.6.2 Endocrinology
ā€ƒā€ƒ11.6.3 Enteral Nutrition
ā€ƒā€ƒ11.6.4 Parenteral Nutrition
ā€ƒā€ƒ11.6.5 Others
ā€ƒ11.7 Historic and Forecast Market Size by Country
ā€ƒā€ƒ11.7.1 Germany
ā€ƒā€ƒ11.7.2 U.K.
ā€ƒā€ƒ11.7.3 France
ā€ƒā€ƒ11.7.4 Italy
ā€ƒā€ƒ11.7.5 Russia
ā€ƒā€ƒ11.7.6 Spain
ā€ƒā€ƒ11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā€ƒ12.1 Key Market Trends, Growth Factors and Opportunities
ā€ƒ12.2 Impact of Covid-19
ā€ƒ12.3 Key Players
ā€ƒ12.4 Key Market Trends, Growth Factors and Opportunities
ā€ƒ12.4 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ12.4.1 IV Cannulas
ā€ƒā€ƒ12.4.2 Infusion Pumps
ā€ƒā€ƒ12.4.3 Needleless Connectors
ā€ƒā€ƒ12.4.4 Intravenous Sets
ā€ƒ12.5 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ12.5.1 Continuous
ā€ƒā€ƒ12.5.2 Secondary IV
ā€ƒā€ƒ12.5.3 IV Push
ā€ƒ12.6 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ12.6.1 Anti-Infective
ā€ƒā€ƒ12.6.2 Endocrinology
ā€ƒā€ƒ12.6.3 Enteral Nutrition
ā€ƒā€ƒ12.6.4 Parenteral Nutrition
ā€ƒā€ƒ12.6.5 Others
ā€ƒ12.7 Historic and Forecast Market Size by Country
ā€ƒā€ƒ12.7.1 China
ā€ƒā€ƒ12.7.2 India
ā€ƒā€ƒ12.7.3 Japan
ā€ƒā€ƒ12.7.4 Singapore
ā€ƒā€ƒ12.7.5 Australia
ā€ƒā€ƒ12.7.6 New Zealand
ā€ƒā€ƒ12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Home Infusion Therapy Market Analysis, Insights and Forecast, 2017-2032
ā€ƒ13.1 Key Market Trends, Growth Factors and Opportunities
ā€ƒ13.2 Impact of Covid-19
ā€ƒ13.3 Key Players
ā€ƒ13.4 Key Market Trends, Growth Factors and Opportunities
ā€ƒ13.4 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ13.4.1 IV Cannulas
ā€ƒā€ƒ13.4.2 Infusion Pumps
ā€ƒā€ƒ13.4.3 Needleless Connectors
ā€ƒā€ƒ13.4.4 Intravenous Sets
ā€ƒ13.5 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ13.5.1 Continuous
ā€ƒā€ƒ13.5.2 Secondary IV
ā€ƒā€ƒ13.5.3 IV Push
ā€ƒ13.6 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ13.6.1 Anti-Infective
ā€ƒā€ƒ13.6.2 Endocrinology
ā€ƒā€ƒ13.6.3 Enteral Nutrition
ā€ƒā€ƒ13.6.4 Parenteral Nutrition
ā€ƒā€ƒ13.6.5 Others
ā€ƒ13.7 Historic and Forecast Market Size by Country
ā€ƒā€ƒ13.7.1 Turkey
ā€ƒā€ƒ13.7.2 Saudi Arabia
ā€ƒā€ƒ13.7.3 Iran
ā€ƒā€ƒ13.7.4 UAE
ā€ƒā€ƒ13.7.5 Africa
ā€ƒā€ƒ13.7.6 Rest of MEA

Chapter 14: South America Home Infusion Therapy Market Analysis, Insights and Forecast,2017-2032
ā€ƒ14.1 Key Market Trends, Growth Factors and Opportunities
ā€ƒ14.2 Impact of Covid-19
ā€ƒ14.3 Key Players
ā€ƒ14.4 Key Market Trends, Growth Factors and Opportunities
ā€ƒ14.4 Historic and Forecasted Market Size By Type
ā€ƒā€ƒ14.4.1 IV Cannulas
ā€ƒā€ƒ14.4.2 Infusion Pumps
ā€ƒā€ƒ14.4.3 Needleless Connectors
ā€ƒā€ƒ14.4.4 Intravenous Sets
ā€ƒ14.5 Historic and Forecasted Market Size By Infusion Type
ā€ƒā€ƒ14.5.1 Continuous
ā€ƒā€ƒ14.5.2 Secondary IV
ā€ƒā€ƒ14.5.3 IV Push
ā€ƒ14.6 Historic and Forecasted Market Size By Application
ā€ƒā€ƒ14.6.1 Anti-Infective
ā€ƒā€ƒ14.6.2 Endocrinology
ā€ƒā€ƒ14.6.3 Enteral Nutrition
ā€ƒā€ƒ14.6.4 Parenteral Nutrition
ā€ƒā€ƒ14.6.5 Others
ā€ƒ14.7 Historic and Forecast Market Size by Country
ā€ƒā€ƒ14.7.1 Brazil
ā€ƒā€ƒ14.7.2 Argentina
ā€ƒā€ƒ14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Global Home Infusion Therapy Market

Base Year:

2023

Forecast Period:

2024-2032

Historical Data:

2017 to 2023

Market Size in 2023:

USD 22.98 Bn.

Forecast Period 2024-32 CAGR:

6.62%

Market Size in 2032:

USD 40.92 Bn.

Segments Covered:

By Type

  • IV Cannulas
  • Infusion Pumps
  • Needleless Connectors
  • Intravenous Sets

By  Infusion Type

  • Continuous
  • Secondary IV
  • IV Push

By Application

  • Anti-Infective
  • Endocrinology
  • Enteral Nutrition
  • Parenteral Nutrition
  • Others

By Region

  • North America (U.S., Canada, Mexico)
  • Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
  • Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
  • Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Hospital-Like Care at Home

Key Market Restraints:

  • Third-Party Service Providers and Low Reimbursement Policies

Key Opportunities:

  • Growing Geriatric Population

Companies Covered in the report:

  • CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc, and Other Major Players
Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Home Infusion Therapy Market research report?

The forecast period in the Home Infusion Therapy Market research report is 2024-2032.

Who are the key players in Home Infusion Therapy Market?

CVS/Coram, Option Care Health, BriovaRx/Diplomat (UnitedHealth Optum), PharMerica, Fresenius Kabi, ICU Medical Inc., B. Braun Melsungen AG, Baxter, BD, Caesarea Medical Electronics, Smiths Medical, Terumo Corporation, JMS Co. Ltd., and Other Major Players.

What are the segments of Home Infusion Therapy Market?

Home Infusion Therapy Market is segmented into Type, Infusion Type, Application and region. By Type, the market is categorized into IV Cannulas, Infusion Pumps, Needleless Connectors, and Intravenous Sets. By Infusion Type, the market is categorized into Continuous, Secondary IV, and IV Push. By Application, the market is categorized into Anti-Infective, Endocrinology, Enteral Nutrition, Parenteral Nutrition, Others. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Home Infusion Therapy Market?

The intravenous or subcutaneous injection of medications or biologicals to a patient at home is termed home infusion therapy. The medicine (antivirals, immune globulin), equipment (pump), and supplies (tubing and catheters) are required for home infusion.

How big is Home Infusion Therapy Market?

The Global Home Infusion Therapy Market size is expected to grow from USD 22.98 billion in 2023 to USD 40.92 billion by 2032, at a CAGR of 6.62% during the forecast period (2024-2032).